Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.56
Feb. 11, 2026 16:00:00- Change 0.0012 (0.21536%)
- Volume 188,506
- Today's Open 0.5565
- Previous Close 0.5572
- Today's High 0.5647
- Today's Low 0.5508
- 52 Week High 2.94
- 52 Week Low 0.281